z-logo
open-access-imgOpen Access
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial
Author(s) -
Alicia GutiérrezValencia,
Omar J. BenMarzoukHidalgo,
Inmaculada RivasJeremías,
Núria Espinosa,
María TrujilloRodríguez,
Tamara FernandezMagdaleno,
Pompeyo Viciana,
Luís F. LópezCortés
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix358
Subject(s) - elvitegravir , darunavir , emtricitabine , cobicistat , medicine , ritonavir , viral load , virology , efavirenz , rilpivirine , human immunodeficiency virus (hiv) , gastroenterology , antiretroviral therapy
There are several regimens for starting antiretroviral treatment, but it remains unknown whether either of them is more advantageous regarding the time course and magnitude of human immunodeficiency virus (HIV) RNA decay in semen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom